HIGH OUTPUT PROTEOMICS FOR DIAGNOSTIC, PROGNOSTIC & THERAPEUTIC APPLICATIONS

PS Biomarker Services provides a toolkit of gel-based/gel-free proteomics technologies and rapid assays to measure and test differential protein expression in disease and therapy. In addition to considerable expertise across the generic technologies which make up proteomics, Proteome Sciences has built up a range of proprietary techniques including TMT® for the gel-free identification and relative quantitation of proprietary proteins in cells, body fluids and tissues with a strong focus on membrane and nuclear proteins. These applications overcome the considerable levels of difficulty and complexity to deliver a comprehensive biomarker service that has been successfully used and validated across a broad range of human diseases and model systems.

PS Biomarker Services provides leading edge proprietary technology in chemical tagging with extensive experience and application across the diverse range of generic proteomic technologies that span sample collection, storage, protein separation, identification and characterisation with bioinformatics and data mining. The high sensitivity and high throughput characteristics from PS Biomarker Services combine to significantly increase the speed, robustness and precision of biomarker discovery/validation and facilitates the rapid transition to multiplex biomarker assays for routine application.

The PS Biomarker Services technology platform is accessible to third parties through outsourcing and strategic alliances. Details can be found under Products and Technologies, together with the list of proprietary biomarkers available for out-licensing in human disease applications.